Diabetes mellitus type 1 future or investigational therapies


 * Associate Editor(s)-In-Chief: Priyamvada Singh, M.B.B.S. [mailto:psingh@perfuse.org];

Entities involved in research
This section is a complete list of mainly commercial companies but also other entities, namely governmental institutions and individual persons, actively involved in research towards finding a cure to diabetes type 1. It does not list research funds, hospitals in which research is undertaken, etc., but only the industrious, actual developers of such products.

Entities are listed along with their status of research in that field, so that also entities which ceased research into finding a cure to diabetes type 1 may be listed.

Entities are alphabetically listed.


 * Cerco Medical – Present status: Unknown
 * Denise Faustman – Present status: Working on immune modification
 * DeveloGen – Present status: Developing DiaPep 277
 * Diamyd Medical – Present status: Developing GAD65-based vaccine (phase III application submitted to the FDA)
 * Encelle – Present status: On hold;  awaiting decision on whether to move forward into encapsulated beta cell transplantation.